AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 27288475
Drug: Vilaprisan (VPR)
RxNorm normalized name: Vpriv
DrugBank: Vilaprisan (DB11971)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vilaprisan (VPR) 5 mg
Trial: 23546172
Drug: Pemetrexed 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemetrexed 600 mg/m², D1 i.v. q21; Carboplatin, AUC 5, D1 i.v. q21 (Arm A)
Trial: 23546172
Drug: Gemcitabine 1,200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine 1,200 mg/m² D1, D8 i.v. q21; Vinorelbine 30 mg/m² D1, D8 i.v. q21 (Arm B)
Trial: 21219813
Drug: Intravenous heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous heparin at 2 IU/ml
Trial: 16860852
Drug: 6 cycles
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 cycles of carboplatin (7.5 AUC over 30 min) and paclitaxel (175 mg/m2 over 3 h) every 21 days
Trial: 16860852
Drug: 3 cycles
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 cycles of carboplatin (7.5 AUC over 30 min) and paclitaxel (175 mg/m2 over 3 h) every 21 days
Trial: 12930333
Drug: Purpura-free treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purpura-free treatment with pulsed-dye laser
Trial: 12930333
Drug: Purpura treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purpura treatment with pulsed-dye laser
Trial: 12930333
Drug: Purpura-free treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purpura-free treatment with pulsed-dye laser (fewer than 250 pulses)
Trial: 12930333
Drug: Purpura-free treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purpura-free treatment with pulsed-dye laser (greater than 250 pulses)
Trial: 1722785
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose aprotinin (2,000,000 KIU loading dose, 500,000 KIU/h infusion until skin closure, plus 2,000,000 KIU in priming volume)
Trial: 1722785
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose aprotinin in risk patients (redo-operations, infective endocarditis)
Trial: 1722785
Drug: Lower dosage
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower dosage aprotinin (2,000,000 KIU during induction or in priming volume only)
Trial: 6918343
Drug: Intravesical prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravesical prostaglandin E2 (1.5 mg in 50 ml 0.9% NaCl)
Trial: 31845865
Drug: Perindopril tert-butylamine
RxNorm normalized name: Perindopril tert-butylamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril tert-butylamine tablets
Trial: 29338762
Drug: Etanercept 50
RxNorm normalized name: etanercept 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 50 mg once weekly plus methotrexate for 36 weeks, followed by randomized treatment with etanercept 50 mg or 25 mg QW plus methotrexate or placebo plus methotrexate for 52 weeks.
Trial: 29338762
Drug: Etanercept 50
RxNorm normalized name: etanercept 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept 50 mg or 25 mg QW plus methotrexate
Trial: 26706043
Drug: l-rhamnose (25.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: l-rhamnose (25.5 g/d)
Trial: 26706043
Drug: inulin (22.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: inulin (22.4 g/d)
Trial: 26706043
Drug: control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: control (no supplement)
Trial: 17509486
Drug: Rotigotine (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rotigotine (up to 16 mg/24 h as a transdermal patch)
Trial: 17509486
Drug: Pramipexole (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pramipexole (up to 4.5 mg/day orally)
Trial: 16202898
Drug: IV dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV dexmedetomidine (0.5 microg/kg loading dose over 20 minutes, followed by continuous infusion at 0.4 microg/kg/h)
Trial: 16202898
Drug: Placebo (IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (IV saline at the same calculated loading and infusion rates)
Trial: 9568047
Drug: IFN‐alpha treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN‐alpha treatment
Trial: 2652231
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg methysergide
Trial: 2652231
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg verapamil
Trial: 22188532
Drug: Ruboxistaurin (RBX),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ruboxistaurin (RBX), 32 mg daily for 8 weeks
Trial: 21092474
Drug: α-lipoic acid
RxNorm normalized name: α-lipoic acid
DrugBank: Lipoic acid (DB00166)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: α-lipoic acid 1800 mg daily for 12 weeks
Trial: 19013300
Drug: Leucine plus
RxNorm normalized name: Leucine
DrugBank: Leucine (DB00149)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Leucine plus glucose (25 g)
Trial: 19201496
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (5 mg daily)
Trial: 12873924
Drug: Small dose
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small dose lidocaine spinal anesthesia
Trial: 29364329
Drug: Comprehensive periodontal
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Comprehensive periodontal treatment (supra and subgingival scaling and root‐planning and periodontal maintenance appointments)
Trial: 29364329
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no comprehensive periodontal treatment)
Trial: 26802147
Drug: mapatumumab-sorafenib (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mapatumumab-sorafenib (30 mg/kg on day 1 per 21-day cycle)
Trial: 26802147
Drug: placebo-sorafenib (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo-sorafenib (400 mg, twice daily per 21-day cycle)
Trial: 24469903
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with normal daily life
Trial: 12070620
Drug: 100%G (maximal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100%G (maximal voluntary contraction for 6 s per set, 12 sets per session)
Trial: 12070620
Drug: 60%G (60%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60%G (60% of MVC for 30 s per set, 4 sets per session)
Trial: 12070620
Drug: Both 100%G
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both 100%G and 60%G
Trial: 31274388
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of oABI and PWI
Trial: 28836279
Drug: Open flap
RxNorm normalized name: BOTTLE OPENER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open flap debridement without antibiotics (control)
Trial: 26785394
Drug: Physiotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiotherapy and Occupational Therapy
Trial: 26785394
Drug: No Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No Therapy
Trial: 22827885
Drug: Goal-setting with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goal-setting with mentoring (goal-setting interview followed by bi-monthly telephone mentoring)
Trial: 15450559
Drug: Naproxen (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen (500 mg q12h for 5 doses via suppository, followed by oral 250 mg q8h for 6 doses)
Trial: 8166478
Drug: Chemotherapy combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy combined with thoracic radiotherapy
Trial: 29016544
Drug: Topical vibration
RxNorm normalized name: interferon beta-1a
DrugBank: Interferon beta-1a (DB00060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical vibration anesthesia during BTX‐A injections
Trial: 29016544
Drug: Control side
RxNorm normalized name: cured fat, pork side bacon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control side (BTX‐A injections only)
Trial: 19368418
Drug: Eltrombopag 50
RxNorm normalized name: eltrombopag 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eltrombopag 50 mg/day
Trial: 17299493
Drug: Lycopene supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lycopene supplementation (15 mg/day)
Trial: 11571763
Drug: Galantamine 36
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galantamine 36 mg/day
Trial: 9512200
Drug: Multidose injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidose injection pen
Trial: 11204933
Drug: Lacidipine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lacidipine (4 mg)
Trial: 8148217
Drug: Lacidipine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lacidipine (4 mg) and Atenolol (100 mg) co-administration
Trial: 1168413
Drug: Alice strain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alice strain live attenuated influenza A (H3N2) vaccine
Trial: 1168413
Drug: Killed parenteral
RxNorm normalized name: Hongo Killer
DrugBank: Undecylenic acid (DB11117)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Killed parenteral (KP) bivalent influenza vaccine
Trial: 30340960
Drug: Early oral
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early oral hydration (EOH)
Trial: 30340960
Drug: Conventional oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional oral hydration (COH)
Trial: 29310386
Drug: Low viscosity
RxNorm normalized name: Gentamicin low viscosity bone cement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low viscosity cement (group L, n = 50)
Trial: 23213101
Drug: FOLFIRINOX (oxaliplatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FOLFIRINOX (oxaliplatin 85 mg/m², irinotecan 180 mg/m², leucovorin 400 mg/m², fluorouracil 400 mg/m² bolus followed by 2400 mg/m² 46-hour continuous infusion, once every 2 weeks)
Trial: 23213101
Drug: gemcitabine (1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: gemcitabine (1,000 mg/m² weekly for 7 of 8 weeks and then weekly for 3 of 4 weeks)
Trial: 19887477
Drug: 1 mg/d
RxNorm normalized name: Lyllana 0.1 MG/Day Transdermal Patch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/d anastrozole
Trial: 19887477
Drug: 10 mg/wk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/wk tamoxifen
Trial: 19887477
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of anastrozole and tamoxifen
Trial: 16400057
Drug: Soybean ferritin
RxNorm normalized name: SOYBEAN
DrugBank: Soybean (DB10568)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soybean ferritin (140 microg Fe as ferritin, 2.5 mg)
Trial: 16400057
Drug: FeSO4 (140
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FeSO4 (140 microg Fe as FeSO4, 2.5 mg)
Trial: 11421999
Drug: Fast infusion
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fast infusion of rilmenidine
Trial: 11421999
Drug: Slow infusion
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow infusion of rilmenidine
Trial: 9347381
Drug: Fluvoxamine-lithium therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine-lithium therapy
Trial: 9347381
Drug: Fluvoxamine monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine monotherapy
Trial: 8482046
Drug: Oral alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral alcohol (0.5 g/kg body weight diluted to 300 ml in sugar-free orange juice)
Trial: 8482046
Drug: Oral alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral alcohol (0.5 g/kg body weight diluted to 300 ml in sugar-free orange juice) during head-up tilt
Trial: 3087252
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of cromolyn
Trial: 3087252
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of cromolyn
Trial: 30587221
Drug: Maintain OAC
RxNorm normalized name: mountain pepper whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintain OAC treatment until the day before surgery and resume OAC treatment the day after surgery.
Trial: 30587221
Drug: Stop OAC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stop OAC treatment (with or without low-molecular-weight heparin bridging therapy) according to the anaesthesia guidelines.
Trial: 24524222
Drug: Formoterol monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol monotherapy
Trial: 22624298
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg of iron
Trial: 22624298
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg of iron in refined palm oil
Trial: 22624298
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg of iron in palm oil with CTCMC (two doses)
Trial: 20171424
Drug: S-amlodipine 5
RxNorm normalized name: S-amlodipine
DrugBank: Levamlodipine (DB09237)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-amlodipine 5 mg
Trial: 20171424
Drug: Amlodipine racemate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine racemate 10 mg
Trial: 12521629
Drug: Beta blockers
RxNorm normalized name: BETA BLOCKERS/RELATED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta blockers discontinued
Trial: 12521629
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of beta blockers
Trial: 12521629
Drug: Withdrawal of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withdrawal of beta blockers
Trial: 8872324
Drug: Doxorubicin 50
RxNorm normalized name: DOXOrubicin 50 mg intravenous powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin 50 mg/m2 i.v. (VAC)
Trial: 8872324
Drug: Mitoxantrone 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitoxantrone 10 mg/m2 (VNC)
Trial: 31425780
Drug: 0.25% delgocitinib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25% delgocitinib ointment
Trial: 31425780
Drug: 0.5% delgocitinib
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% delgocitinib ointment
Trial: 26395834
Drug: CT-P13 (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CT-P13 (5 mg/kg)
Trial: 26795209
Drug: RP (5
RxNorm normalized name: Ropinirole
DrugBank: Ropinirole (DB00268)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: RP (5 mg/kg)
Trial: 15875154
Drug: Simvastatin 10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 10, 20, 40 mg
Trial: 12519867
Drug: Carbenoxolone (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbenoxolone (100 mg every 8 h, orally, for 7 d)
Trial: 7751519
Drug: Cetirizine therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine therapy
Trial: 6626483
Drug: Cognitive behaviour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behaviour therapy + medication
Trial: 31928076
Drug: IGFBP3 (insulin-like
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IGFBP3 (insulin-like growth factor-binding protein 3)
Trial: 26978049
Drug: Tenoten children
RxNorm normalized name: Pediaclear Childrens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenoten children (1 tablet 3 times a day for 12 weeks)
Trial: 9463203
Drug: 5 ml
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml of 2% mepivacaine and 1 ml (30 mg) of ketorolac
Trial: 9463203
Drug: 5 ml
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml of 2% mepivacaine and 1 ml of saline solution
Trial: 9463203
Drug: 5 ml
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml of 2% mepivacaine and 1 ml of saline solution plus 30 mg of ketorolac intravenously
Trial: 8485325
Drug: Injection sclerotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection sclerotherapy of esophageal varices (Control)
Trial: 3446537
Drug: Day case
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Day case strabismus surgery without post-operative topical medication
Trial: 3446537
Drug: Overnight stay
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overnight stay with topical antibiotic and anti-inflammatory therapy for 14 days
Trial: 22929730
Drug: Low-dose dexmedetomidine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose dexmedetomidine (target = 0.15 ng/ml plasma)
Trial: 14520131
Drug: Gabapentin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (400 mg qid)
Trial: 11105733
Drug: Herbal and
RxNorm normalized name: ALLANTOIN 1 g in 100 g TOPICAL CREAM [Scar Reducer Intensive Herbal and Nutrient]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal and over-the-counter antidepressants
Trial: 1558003
Drug: Antihypertensive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive treatment for ISH
Trial: 3891285
Drug: Filtered amphotericin
RxNorm normalized name: amphotericin
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Filtered amphotericin B infusions (1 micron filter)
Trial: 3891285
Drug: Unfiltered amphotericin
RxNorm normalized name: amphotericin
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfiltered amphotericin B infusions
Trial: 29164960
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 0.05% cream plus emollient (Group A)
Trial: 27470152
Drug: Cefazolin 2
RxNorm normalized name: cefazolin 2000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefazolin 2 g intravenously 30 minutes prior to the procedure (n = 91)
Trial: 18680228
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (5 mg daily for 3 years)
Trial: 8905278
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose fentanyl/midazolam anesthesia
Trial: 8905278
Drug: Thoracolumbar epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thoracolumbar epidural blockade with high dose fentanyl/midazolam anesthesia
Trial: 6410898
Drug: 1 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g/kg ideal body weight amino acid infusion
Trial: 6410898
Drug: 2 g/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g/kg ideal body weight amino acid infusion
Trial: 24107112
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg naltrexone (high-dosage group)
Trial: 24107112
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg naltrexone (low-dosage group)
Trial: 24107112
Drug: Injectable depot
RxNorm normalized name: methylprednisolone Injection [Depo-Medrol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injectable depot naltrexone (400 mg)
Trial: 20622475
Drug: Statin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin treatment (at least 5 days before operation)
Trial: 15138760
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) 0.3 mg/kg acute dose
Trial: 15138760
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) 0.6 mg/kg acute dose
Trial: 15138760
Drug: Chronic Methylphenidate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronic Methylphenidate administration
Trial: 12243813
Drug: Oxaliplatin (OXA)
RxNorm normalized name: Oxaliplatin
DrugBank: Oxaliplatin (DB00526)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oxaliplatin (OXA) 25 mg/m²/day in 30-min infusions, bolus leucovorin (LV) 20 mg/m²/day, bolus 5-FU 375 mg/m²/day, given on 4 days during Weeks 1 and 5 of radiotherapy (50.4 Gy). A single OXA dose (50 mg/m²) was given on the third week of radiotherapy.
Trial: 11165426
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment with exposure therapy in a group context
Trial: 11165426
Drug: Comparison treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison treatment avoiding trauma focus
Trial: 27214168
Drug: ABCT (Alcohol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABCT (Alcohol Behavioral Couple Therapy)
Trial: 20035583
Drug: Lisdexamfetamine dimesylate
RxNorm normalized name: Lisdexamfetamine Dimesylate
DrugBank: Lisdexamfetamine (DB01255)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lisdexamfetamine dimesylate (LDX) 20-70 mg/day
Trial: 20384496
Drug: 2 doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 doses of 7-valent PCV (PCV7) at ages 4 and 6 months